Introduction
============

Plant virus capsids are highly suitable for nanotechnological applications because they can be modified by genetic engineering or chemical conjugation to exposed amino acid residues. The capsids comprise multiple copies of one or more identical CP subunits, thus providing many different possibilities for the selective attachment and presentation of numerous organic and inorganic molecules, including metals, semi-conductors, carbohydrates, peptides and larger proteins such as antibodies. Various molecules have already been displayed on the surface of CPMV and TMV capsids ([@B32]; [@B5]; [@B12]; [@B44],[@B45]; [@B34]; [@B26]; [@B6]). Therefore, plant viruses are suitable as building blocks for applications in areas as diverse as electronics and vaccination. Fluorescence-tagged viral nanoparticles can also be used as biomedical imaging devices ([@B24]; [@B29]; [@B9]; [@B50]; [@B22]; [@B41]). In this context, the filamentous PVX has proven superior to spherical CPMV particles because PVX achieves enhanced tumor homing and retention and can carry a larger payload ([@B40]).

TMV, the type member of the genus *Tobamoviruses* (family *Virgaviridae*), is one of the best-characterized plant viruses and is a popular choice for nanotechnological applications ([@B18]; [@B31]; [@B7]; [@B36]; [@B1]; [@B27]; [@B8]). The 6.4-kb RNA genome of TMV has a plus-sense polarity, a 5′-methylguanosine cap and a tRNA-like structure at the 3′ end ([@B53]; [@B49]). The RNA is encapsidated by 2130 identical helically assembled CP subunits to form a rigid rod-shaped particle ([@B20]). Small peptides can be displayed on the surface of TMV by inserting the coding sequence at either the 5′ or 3′ end of the *cp* gene ([@B4]). There are further potential insertion points between amino acid positions 63 and 66 ([@B46]) and close to the C-terminus between positions 154 and 155 ([@B3]). Protein fusions can also be generated using a leaky stop codon ([@B42]). For PVX, an alternative methodology to display a target protein is the insertion of the FMDV 2A sequence between the target gene and the *cp*, hence a ribosomal skip occurs during translation, leading to the expression of the CP fusion protein, free target protein as well as wild-type CP ([@B14]; [@B16],[@B17]). The FMDV 2A sequence has previously been used in PVX vectors to avoid unfavorable limitations of CP fusions ([@B14]; [@B23]; [@B41]; [@B47]), but to our knowledge it has not yet been used in a TMV CP fusion protein.

Fluorescent proteins such as GFP are widely used as reporters in prokaryotic and eukaryotic cells, but suffer from disadvantages such as their complex structure, large size, and their dependence on pH and oxygen ([@B38]; [@B19]). A suitable alternative is the improved LOV2 (light, oxygen or voltage sensing) domain of *Arabidopsis thaliana* phototropin 2, designated iLOV ([@B11]). A flavin mononucleotide serves as the chromophore within the LOV domain. The 13-kDa monomeric iLOV protein is 113 amino acids in length ([@B13]). [@B11] have already shown that the reversible photobleaching properties of iLOV make it particularly suitable as a reporter for TMV infection and movement.

In order to display iLOV on the surface of TMV, we genetically fused the iLOV sequence to the *cp* gene and visualized the systemic spread of recombinant viruses by *in planta* fluorescence monitoring. We found that viruses carrying a direct fusion of iLOV and CP initially remained predominantly in the stem, but those with an additional FMDV 2A sequence achieved a rapid systemic infection. As previously observed for analogous PVX vectors, the iLOV-2A-CP~TMV~ construct resulted in the expression of an iLOV-CP~TMV~ fusion protein, free CP~TMV~ and free iLOV. TMV particles presenting iLOV were identified by immunogold electron microscopy. Therefore, our data confirm that TMV vectors containing the FMDV 2A sequence are suitable for the display of proteins at least as large as the 13-kDa monomeric iLOV protein, which represents a protein that usually has limitations for fusions to the TMV CP due to the amino acid sequence.

Materials and Methods {#s1}
=====================

Vector Construction
-------------------

The pSC1001a vector containing the iLOV sequence was a kind gift from S. Chapman (The James Hutton Institute, Dundee, Scotland). The PVX-based vector pPVX-iLOV-2A-CP~PV\ X~ was constructed by amplifying the iLOV sequence using specific primers NheI-iLOV and iLOV-BspEI, which also introduced the named restriction sites (**Table [1](#T1){ref-type="table"}**). The PCR products were inserted into the pCR2.1-TOPO cloning vector and introduced into competent *Escherichia coli* TOP10 cells according to the manufacturer's recommendations (Thermo Fisher Scientific, Karlsruhe, Germany). A control PCR using the M13 forward and reverse primers was carried out to confirm the presence of the target gene. The iLOV sequence was digested with NheI and BspEI and transferred to vector pTCXIIc ([@B41]) which was linearized with the same enzymes to remove the mCherry sequence, leaving the FMDV 2A sequence as a ligation target. The integrity of the final plasmid was confirmed by PCR using primers TGB-fw and CX1.

###### 

Oligonucleotides used for PCR.

  Primer name       Nucleotide sequence (5′--3′)
  ----------------- --------------------------------------------------------------------
  2A-rev            CCCGGGGTTGGACTCGACGTCT
  CPTMV-G4S         GCTACCGCCTCCACCACTCCCTCCACCGCCGCTACCTCCACCTCCAGTAGCCGGAGTTGTG
  CPTMV-iLOV        CTGGACCACAACTCCGGCTACTGCAAGCATAGAGAAGAATTTCGTC
  CPTMV-rev         AGTAGCCGGAGTTGTGGTCCAG
  CPTMV-Stop-NotI   ACCGCGGCCGCTTAAGTAGCCGGAG
  CX1               TTGAAGAAGTCGAATGCAGC
  G4S-iLOV          GGAGGTGGAGGTAGCGGCGGTGGAGGGAGTGGTGGAGGCGGTAGCGCAAGCATAGAGAAGAATTTC
  iLOV-BspEI        TTTTCCGGATACATGATCACTTCCATCGA
  iLOV-Stop-NotI    TTTGCGGCCGCTTATACATGATCACTTCCATCGAGC
  M13 reverse       ACACAGGAAACAGCTATGAC
  M13 forward       GTTGTAAAACGACGGCCAGT
  N-2A-CPTMV        GCTTGCGGGAGACGTCGAGTCCAACCCCGGGCCTTATACAATCAACTCTCCG
  NheI-iLOV         AAAGCTAGCATGGCAAGCATAGAGAAGAA
  PacI-CPTMV        AAATTAATTAAATGCCTTATACAATCAACTCTC
  PacI-iLOV         AAATTAATTAAATGGCAAGCATAGAGAAGAATTTCGTCATCACTG
  TGB-fw            AAGGGCCATTGCCGATCTCAAGC
  TMV5482f          TTGATGAGTTCATGGAAG
  TMV6269r          TTCGATTTAAGTGGAGGG

The TMV-based vectors containing the iLOV sequence were constructed by splice overlap extension (SOE) PCR. The TMV *cp* sequence was amplified from vector pET22b-TMVCP-His (unpublished data) using primers PacI-CPTMV and CPTMV-rev or PacI-CPTMV and CPTMV-G4S, whereas the iLOV sequence was amplified from vector pPVX-iLOV-2A-CP~PV\ X~ using primers CPTMV-iLOV and iLOV-Stop-NotI or G4S-iLOV and iLOV-Stop-NotI. The primer combinations were chosen according to whether or not the linker sequence was required. The resulting CP and iLOV fragments were combined and re-amplified with flanking primers in two subsequent PCRs. The CP~TMV~-iLOV and CP~TMV~-G~4~S-iLOV fusion sequences were inserted into vector pCR2.1-TOPO for the transformation of competent *E. coli* TOP10 cells as described above. The integrity of the vectors was confirmed by PCR using the M13 forward and reverse primers. The pCR2.1 CP~TMV~-iLOV and pCR2.1 CP~TMV~-G~4~S-iLOV vectors were digested with PacI and NotI and the inserts were transferred to vector pTRBOc ([@B25]) which had been linearized with the same enzymes, thus fusing the iLOV sequence to the C-terminus of the TMV CP either directly or via the (G~4~S)~3~ linker. The integrity of the final vectors pTMV-CP~TMV~-iLOV and pTMV-CP~TMV~-G~4~S-iLOV was confirmed by PCR using primers TMV5482f and TMV6269r.

Vector pTMV-iLOV-2A-CP~TMV~ was constructed by amplifying the iLOV sequence from pPVX-iLOV-2A-CP~PV\ X~ using primers PacI-iLOV and 2A-rev, whereas the TMV CP sequence was amplified using primers N-2A-CPTMV and CPTMV-Stop-NotI. The fragments were joined by SOE-PCR, re-amplified and transferred to vector pTRBOc as described above to produce final vector pTMV-iLOV-2A-CP~TMV~. The integrity of the vector was determined by PCR as described above.

The subgenomic expression vector was produced by amplifying the iLOV sequence using primers PacI-iLOV and iLOV-Stop-NotI. The product was transferred to vector pCR2.1-TOPO and its integrity was confirmed as described above, and then the insert was excised with PacI and NotI and transferred to vector pJL ([@B25]), which had been linearized with the same enzymes. The integrity of the resulting vector pJL-iLOV was confirmed by PCR using primers TMV5482f and TMV6269r.

In TMV-derived viral vectors, the expression of the proteins of interest is controlled by the CP subgenomic promoters. All vectors were maintained and amplified in the *E. coli* strain DH5α and their integrity was confirmed by sequencing prior to the inoculation of *N. benthamiana* plants. Full sequences of the recombinant viruses can be found online as Supplementary Material.

Infection and Cultivation of *Nicotiana benthamiana* Plants
-----------------------------------------------------------

Three leaves from 4-week-old *N. benthamiana* plants were each inoculated with 10 μg of pTMV-CP~TMV~-iLOV, pTMV-CP~TMV~-G~4~S-iLOV, pTMV-iLOV-2A-CP~TMV~, pJL-iLOV, or pPVX-iLOV-2A-CP~PV\ X~. The leaf surface was gently abraded with Celite 545. After incubation for 15--20 min, the leaves were rinsed with water to remove Celite and excess DNA. The plants were cultivated in a phytochamber (12-h photoperiod, 5000--10,000 lux, 26°C/20°C light/dark temperature, humidity 70%).

Protein Isolation and Analysis
------------------------------

SDS-PAGE was carried out using 12% resolving gels and a 4% stacking gels loaded with 20 μl of sample per lane. Samples for SDS-PAGE followed by western blot were prepared by extracting total protein from systemically infected leaves 1:2 in PBS, followed by centrifugation (20,000 × *g*, 15 min, 4°C) and boiling for 5 min in 5× reducing loading buffer ([@B21]). For in-gel fluorescence detection by UV light, the samples were prepared as above but were not boiled. The separated proteins were either stained with Coomassie Brilliant Blue G250 or transferred onto a Hybond C nitrocellulose membrane (GE Healthcare, Munich, Germany) using the semi-dry blotting system (BioRad, Munich, Germany). The membrane was blocked for at least 30 min in 4% skimmed milk in PBS. The iLOV protein was detected at room temperature overnight using an iLOV-specific polyclonal antibody (kindly provided by John Christie, Institute of Molecular Cell and Systems Biology, University of Glasgow, Scotland) diluted 1:4000 in PBS, followed by incubation for at least 2 h with a secondary alkaline phosphatase-conjugated goat-anti-rabbit (GAR^AP^) antibody (Dianova, Hamburg, Germany) diluted 1:5000 in PBS. The TMV and PVX were detected using a TMV-specific polyclonal antibody (Bioreba, Reinach, Switzerland) or a PVX-specific polyclonal antibody (DSMZ, Braunschweig, Germany) each diluted 1:5000 in PBS, followed by the secondary GAR^AP^ antibody as described above. The signals were visualized with nitroblue tetrazolium chloride/5-bromo-4-chloro-3-indolyphosphate (NBT/BCIP) *p*-toluidine salt (Roth, Karlsruhe, Germany). The P7712 Pre-stained Protein Standard (New England Biolabs, Ipswich, Massachusetts, USA) was used for sizing. We estimated the ratio of fusion protein and free iLOV by densitometric analysis of the αiLOV western blot by using ImageJ v1.50f software. The value of the iLOV-2A-CP~TMV~ band was divided by the density values of all bands for the fusion protein and free iLOV, multiplied by 100.

Analysis of Viral RNA
---------------------

For the sequences analysis of progeny viruses, total RNA from systemically infected *N. benthamiana* leaves was extracted using the RNeasy Plant Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. 2 μg RNA samples were treated with 3 U of DNaseI (Thermo Fisher Scientific, Waltham, United States) prior to cDNA synthesis by M-MLV Reverse Transcriptase RNaseH Minus Point Mutant (Promega, Madison, WI, United States). 1 μg DNase-digested RNA was mixed with 0.5 μl TMV6269r primer, incubated for 10 min at 80°C and for 10 min at 4°C allowing primer annealing. For cDNA synthesis 5 μl 5x M-MLV reaction buffer, 1 mM dNTPs, 2.5 μl DEPC-H~2~O, and 1 μl M-MLV reverse were added and reverse transcription was carried out (30 min at 40°C, 20 min at 45°C, 20 min at 50°C, 20 min at 55°C, 20 min at 70°C). The integrity of CP~TMV~-iLOV, CP~TMV~-G~4~S-iLOV, iLOV-2A-CP, and iLOV was confirmed by PCR using the TMV5482f and TMV6269r primers amplifying a region between the movement protein and the CP~TMV~ coding sequence. The products were resolved by 1.2% agarose gel electrophoresis in 1x TAE buffer. Ethidium bromide was used to visualize the DNA under UV light.

Preparation of Grids and Transmission Electron Microscopy
---------------------------------------------------------

Pioloform-coated nickel grids (Plano, Wetzlar, Germany) were used for all preparations. For immunogold decoration the grids were incubated on a drop of systemically infected plant leaf extract for 30 min at room temperature, washed once with 20 drops of PBS containing 0.1% Tween-20 (PBST), and blocked with 0.5% bovine serum albumin (Sigma, Taufkirchen, Germany) in PBS for 20 min. After blocking, adsorbed hybrid particles were incubated for at least 2 h with the iLOV-specific antiserum described above (diluted 1:100), washed again and the particles were detected with a goat-anti-rabbit antibody conjugated to 15-nm gold particles (British BioCell, Cardiff, United Kingdom) for at least 2 h. Before staining with five drops of 1% uranyl acetate, the grids were extensively washed with PBST and twice with water. Transmission electron microscopy was carried out using a Zeiss EM10 microscope (Carl Zeiss AG, Jena, Germany).

Hybrid particles were captured from systemically infected leaf extracts by an αiLOV antibody. Therefore, the grids were incubated for 30 min on the iLOV-specific antibody, before washing and blocking with 0.5% BSA as described above. After another washing step the antibody was used to capture the TMV-iLOV particles from leaf extracts. The grids were washed and stained as described above.

Results
=======

Vector Construction and Inoculation of Plants
---------------------------------------------

We constructed three TMV-based vectors (**Figure [1](#F1){ref-type="fig"}**) in which the iLOV coding sequence was joined to the 3′ end of the TMV *cp* gene (a) directly or (b) via a glycine-serine linker. Furthermore, the sequence was fused with (c) a FMDV 2A sequence to the 5′ end of the *cp* gene to enable a ribosomal skip during translation. A fourth TMV-based vector with a CP subgenomic promoter was used to express the free iLOV protein. As a positive control the iLOV sequence was also fused to the 5′ end of the PVX CP via the FMDV 2A sequence.

![Schematic overview of TMV- and PVX-derived vectors for the expression of iLOV. The target genes are depicted as part of the full viral genomes. The iLOV sequence was added either as a direct fusion or with an intervening (G~4~S)~3~ linker to the 3′ end of the TMV CP gene. The iLOV gene was also fused via the FMDV 2A sequence to the 5′ end of the TMV CP and was expressed as a free polypeptide under the control of a subgenomic promoter (arrows). The pPVX-iLOV-2A-CP~PV\ X~ vector was generated by fusing the iLOV sequence via the FMDV 2A sequence to the 5′ end of the PVX CP gene. Abbreviation: aa = length of amino acid sequence.](fpls-08-01125-g001){#F1}

The vectors were used to inoculate *Nicotiana benthamiana* plants, resulting in systemic infections in all cases as revealed by the green fluorescence of the iLOV polypeptide, even in plants inoculated with pTMV-CP~TMV~-iLOV and pTMV-CP~TMV~-G~4~S-iLOV (**Figure [2](#F2){ref-type="fig"}**). However, long-distant movement was delayed in plants infected with pTMV-CP~TMV~-iLOV and pTMV-CP~TMV~-G~4~S-iLOV, and the fluorescence signal was therefore present mostly in the stem whereas only small portions of leaf tissue showed iLOV fluorescence 21--29 dpi (**Figures [2B,C](#F2){ref-type="fig"}**). Plants infected with pTMV-iLOV-2A-CP~TMV~ and pPVX-iLOV-2A-CP~PV\ X~ showed systemic fluorescent spots from 6 to 7 dpi onward. In addition to the bright green fluorescence, the plants inoculated with pTMV-iLOV-2A-CP~TMV~ also showed severe symptoms of TMV infection, including mosaic-like mottling, dwarfing and necrosis at 11 dpi (**Figure [2D](#F2){ref-type="fig"}**). The necrotic lesions were more severe when the free iLOV polypeptide was expressed from the subgenomic promoter (**Figure [2F](#F2){ref-type="fig"}**).

![Symptoms of infection and detection of fluorescence produced in *N. benthamiana* plants inoculated with TMV- and PVX-derived vectors for the expression of iLOV. **(A)** Non-infected *N. benthamiana* plant and plants infected with **(B)** pTMV-CP~TMV~-iLOV, **(C)** pTMV-CP~TMV~-G~4~S-iLOV, **(D)** pTMV-iLOV-2A-CP~TMV~, **(E)** pPVX-iLOV-2A-CP~PV\ X~, and **(F)** pJL-iLOV were viewed under UV light or normal light 11--29 dpi depending on the infection progress. All plants showed evidence of systemic infection as revealed by the green fluorescence. Plants infected with pPVX-iLOV-2A-CP~PV\ X~, pTMV-iLOV-2A-CP~TMV~, or pJL-iLOV showed the most severe symptoms, including necrotic leaves.](fpls-08-01125-g002){#F2}

Analysis of Recombinant TMV Particles Displaying iLOV
-----------------------------------------------------

Leaves were collected from plants systemically infected with pTMV-CP~TMV~-iLOV, pTMV-CP~TMV~-G~4~S-iLOV, pTMV-iLOV-2A-CP~TMV~, pJL-iLOV, and pPVX-iLOV-2A-CP~PV\ X~, and the modified CPs were characterized by SDS-PAGE and western blotting using antibodies specific for TMV or iLOV.

Western blots of total leaf extracts from plants infected with pTMV-CP~TMV~-iLOV and pTMV-CP~TMV~-G~4~S-iLOV showed only faint bands at the anticipated molecular weights of 30.5 and 31.4 kDa when probed with the TMV-specific antibody (**Figure [3B](#F3){ref-type="fig"}**) but strong signals when probed with the iLOV-specific antibody (**Figure [3C](#F3){ref-type="fig"}**), probably due to epitope access and weak systemic leaf infection. The TMV-specific antibody also revealed a 17.6 kDa band corresponding to the free TMV CP (**Figure [3B](#F3){ref-type="fig"}**) but as expected we were unable to detect the free iLOV polypeptide, either by western blot or under UV light. Weak bands corresponding to the CP~TMV~-iLOV and CP~TMV~-G~4~S-iLOV fusion proteins were also revealed under UV light. The weakness of the signal was probably due to the high background caused by the autofluorescence of the leaf extracts (**Figure [3D](#F3){ref-type="fig"}**).

![Analysis of infected *N. benthamiana* leaves expressing iLOV fusion proteins. Extracts of systemically infected leaf extracts were separated by SDS-PAGE (20-μl samples) and proteins were **(A)** stained with Coomassie Brilliant Blue G250, **(B,C,E)** transferred to a nitrocellulose membrane for western blotting, or **(D)** detected under UV light. MW = P7712 Pre-stained Protein Standard, *N. benthamiana* = extract from non-infected leaf. CP~TMV~-His = TMV CP-His (control), PVX = PVX particles. Other lanes are extracts from leaves infected with the corresponding viral vectors. Antibody detection: **(B)** TMV-specific antibody and GAR^AP^, **(C)** iLOV-specific antibody and GAR^AP^, **(E)** PVX-specific antibody and GAR^AP^.](fpls-08-01125-g003){#F3}

Western blots of total leaf extracts from plants infected with pTMV-iLOV-2A-CP~TMV~ showed only a faint band at the anticipated molecular weight of 32.5 kDa when probed with the TMV-specific antibody (**Figure [3B](#F3){ref-type="fig"}**) or with the iLOV-specific antibody (**Figure [3C](#F3){ref-type="fig"}**). As above, the TMV-specific antibody also detected a 17.6 kDa band corresponding to the free TMV CP. However, in this case the iLOV-specific antibody detected not only the fusion protein but also the 13 kDa free iLOV polypeptide (**Figure [3B](#F3){ref-type="fig"}**). Only the latter could be detected under UV light (**Figure [3D](#F3){ref-type="fig"}**). Densitometric analyses show a ratio of 2:3 for iLOV-2A-CP~TMV~ fusion protein to free iLOV.

The TMV vector, plants infected with pPVX-iLOV-2A-CP~PV\ X~ displayed a strong signal for the fusion protein (39.9 kDa) in western blots probed with either the PVX-specific or iLOV-specific antibodies (**Figures [3E,C](#F3){ref-type="fig"}**). A 25 kDa band also detected by western blot with the PVX-specific antibody represented the free PVX CP (**Figure [3E](#F3){ref-type="fig"}**). The 13 kDa free iLOV polypeptide was detected by western blot using the iLOV-specific antibody (**Figure [3C](#F3){ref-type="fig"}**) and also produced a strong signal under UV light (**Figure [3D](#F3){ref-type="fig"}**).

Leaf extracts from plants infected with the TMV subgenomic promoter control construct yielded strong signals for both the free TMV CP and the free iLOV polypeptide when detected with the corresponding antibodies (**Figures [3B,C](#F3){ref-type="fig"}**), and the iLOV polypeptide was also detected under UV light as expected (**Figure [3D](#F3){ref-type="fig"}**).

Transmission electron microscopy confirmed the presence of iLOV on the surface of CP~TMV~-iLOV (**Figure [4B](#F4){ref-type="fig"}**), CP~TMV~-G~4~S-iLOV (**Figure [4C](#F4){ref-type="fig"}**), iLOV-2A-CP~TMV~ (**Figure [4D](#F4){ref-type="fig"}**), and iLOV-2A-CP~PV\ X~ particles (**Figure [4G](#F4){ref-type="fig"}**) due to the recognition of the iLOV polypeptide by specific antibodies conjugated to 15-nm gold particles. In contrast to the iLOV-2A-CP~TMV~ and iLOV-2A-CP~PV\ X~ particles, only a few decorated TMV particles were observed in plants expressing CP~TMV~-iLOV and CP~TMV~-G~4~S-iLOV. Moreover, the TMV-iLOV particles were captured from leaf extracts by the iLOV-specific antibody (**Figures [4I](#F4){ref-type="fig"}--[K](#F4){ref-type="fig"}**). Although particles were not decorated in plants infected with pJL-iLOV expressing the free iLOV polypeptide from a subgenomic promoter (**Figure [4E](#F4){ref-type="fig"}**), some particles were captured by the iLOV antibody (**Figure [4L](#F4){ref-type="fig"}**), and were also detected in the western blot probed with this antibody (**Figure [3C](#F3){ref-type="fig"}**). TMV and PVX particles without fusion proteins were not decorated by the antibodies as expected (**Figures [4F,H](#F4){ref-type="fig"}**).

![Electron micrographs of infected leaf extracts expressing recombinant TMV and PVX particles displaying iLOV. **(A--H)** Immunogold decoration: **(A)** Non-infected *N. benthamiana* leaf extract, **(B)** CP~TMV~-iLOV, **(C)** CP~TMV~-G~4~S-iLOV, **(D)** iLOV-2A-CP~TMV~, **(E)** iLOV SGP, **(F)** TMV particles, **(G)** iLOV-2A-CP~PV\ X~, and **(H)** PVX particles. The particles were detected with an iLOV-specific antibody and a goat anti-rabbit secondary antibody labeled with 15-nm gold. **(I--L)** Enrichment of particles by capturing with iLOV-specific antibody: **(I)** CP~TMV~-iLOV, **(J)** CP~TMV~-G~4~S-iLOV, **(K)** iLOV-2A-CP~TMV~, **(L)** iLOV SGP. Bar = **(A)** 1 μm, **(B,D--L)** = 500 nm, **(C)** = 200 nm.](fpls-08-01125-g004){#F4}

Total RNA was isolated from *N. benthamiana* leaves systemically infected with pTMV-CP~TMV~-iLOV, pTMV-CP~TMV~-G~4~S-iLOV, pTMV-iLOV-2A-CP~TMV~, or pJL-iLOV. Non-infected leaves served as negative controls. Residual RNA was removed by RNase prior to reverse transcription of the viral RNA with a TMV specific primer. The cDNA and control plasmids were amplified by primers flanking a region between the *movement protein* and *cp* genes (**Figure [5](#F5){ref-type="fig"}**). pTMV-CP~TMV~-iLOV and pTMV-CP~TMV~-G~4~S-iLOV infected leaves should have yield fragments of 1216 and 1261-bp in size, but revealed only deleted versions with a size of ∼900 bp. Infections with pTMV-iLOV-2A-CP~TMV~ and pJL-iLOV indicated products of 1276 or 733 bp in RT-PCR analysis, as expected.

![RT-PCR analysis of infected plant material expressing iLOV. RT-PCR products of isolated RNA from *N. benthamiana* (non-infected plant), and plants infected with pTMV-CP~TMV~-iLOV, pTMV-CP~TMV~-G~4~S-iLOV, pTMV-iLOV-2A-CP~TMV~, and pJL-iLOV. Plasmid DNA of the vectors serves as control in PCR. M: GeneRuler 100 bp Plus DNA Ladder.](fpls-08-01125-g005){#F5}

Discussion
==========

The capsids of plant viruses are widely used as building blocks for nanotechnological applications because they are suitable as scaffolds for the display of diverse functional molecules. The C-terminus of each PVX CP subunit is located within the PVX particle whereas the N-terminus projects from the outer surface. In contrast, both the N-terminus and C-terminus of each TMV CP subunit are exposed on the external surface and hence provide excellent insertion sites for the display of fusion peptides.

In this study, TMV-derived vectors were generated to display the monomeric fluorescent protein iLOV (**Figure [1](#F1){ref-type="fig"}**). The iLOV sequence was genetically fused to the 3′ end of the TMV CP either directly or via a glycine-serine linker, or with the FMDV 2A sequence at the 5′ end of the CP. As positive controls, iLOV was expressed as a PVX CP fusion using the FMDV 2A sequence, and as a free iLOV polypeptide under the control of a duplicated subgenomic promoter.

The iLOV polypeptide has a molecular weight of 13 kDa and is therefore even smaller than the 15.5 kDa ProtA fragment, which is known to form hybrid TMV particles efficiently when expressed as a CP fusion ([@B51]). We therefore anticipated that iLOV could be displayed on the surface of TMV, but the multiplication of the pTMV-CP~TMV~-iLOV and pTMV-CP~TMV~-G~4~S-iLOV viral vectors was inefficient, potentially due to steric hindrance that may affect particle assembly, movement or more likely phloem unloading. Although each of the vectors we tested was able to infect *N. benthamiana* plants systemically, as revealed by the green iLOV fluorescence, long-distance movement was delayed in plants inoculated with pTMV-CP~TMV~-iLOV or pTMV-CP~TMV~-G~4~S-iLOV. More precisely, in plants infected with the C-terminal iLOV direct fusion constructs, the fluorescence remained mainly in the stem, which again suggests inefficient particle assembly due to steric hindrance. The presence of peptides fused to the CP increases the genetic load and can interfere with TMV particle assembly, local and systemic movement, and in some cases can even induce the expression of host defense genes ([@B2]; [@B3]). Therefore, the characteristics of the target peptide should be tailored to facilitate particle assembly, which can be influenced by steric effects ([@B15]) and the pI of the fusion peptide ([@B3]). Peptide fusions with pI values equal to or lower than that of the wild-type TMV CP can move systemically, although additional positively charged amino acids can inhibit virus movement. This results in the selection of point mutations and deletions that restore normal virus functions, as well as the appearance of necrotic lesions in the leaves ([@B2]; [@B3]). The iLOV polypeptide comprises only ∼13% positively charged amino acids and the CP~TMV~-iLOV fusion protein has a pI of 4.8, which is comparable to the pI of wild-type CP~TMV~ (pI 4.5). The restricted systemic movement of CP~TMV~-iLOV and CP~TMV~-G~4~S-iLOV TMV particles must therefore reflect the size of the fused polypeptide.

Infected plants with severe TMV or PVX symptoms such as necrosis were observed following inoculation with pTMV-iLOV-2A-CP~TMV~, pPVX-iLOV-2A-CP~PV\ X~ and pJL-iLOV (**Figure [2](#F2){ref-type="fig"}**). This may reflect the ability of iLOV to produce ROS that can interfere with host metabolism and induce a hypersensitive response ([@B39]; [@B37]). The iLOV polypeptide was expressed as a CP fusion protein but also as a free protein due to the use of the 2A peptide linker, allowing hybrid particles to assemble and move systemically ([@B14]). The concentration of ROS might therefore be much higher in plants infected with pTMV-iLOV-2A-CP~TMV~, pPVX-iLOV-2A-CP~PV\ X~, or pJL-iLOV than those infected with pTMV-CP~TMV~-iLOV or pTMV-CP~TMV~-G~4~S-iLOV, resulting in severe symptoms such as necrotic lesions (**Figure [2](#F2){ref-type="fig"}**).

The expression of the CP~TMV~-iLOV and iLOV-2A-CP~TMV~ fusion proteins as well as free CP~TMV~ and free iLOV was confirmed by in-gel UV fluorescence analysis and western blots with antibodies specific for either TMV or iLOV (**Figure [3](#F3){ref-type="fig"}**). These data confirm that compositional limitations for fusions to the TMV CP fusion proteins can be overcome not only by inserting a read-through sequence motif at the 3′ end of the TMV *cp* gene ([@B46]), but also by including the FMDV 2A sequence as an N-terminal fusion. pPVX-iLOV-2A-CP~PV\ X~ or pTMV-iLOV-2A-CP~TMV~ constructs expressed larger amounts of the free iLOV polypeptide than CP fusion proteins (**Figure [3](#F3){ref-type="fig"}**).

Ribosomal skip sequences are widely used with PVX vectors to facilitate the assembly of hybrid particles, as reported for fusions containing the 45 kDa VP6 rotavirus capsid protein ([@B35]), GFP ([@B14]), various epitopes ([@B30]; [@B52]; [@B48]), a single-chain antibody fragment ([@B43]) and lipase ([@B10]). The major disadvantage of the utilization of the FMDV 2A ribosomal skip sequence is the unpredictable ratio of fusion protein to CP ([@B28]; [@B33]), but this can be adjusted through the use of length-optimized variants of the 2A sequence ([@B33]). When displaying epitopes on the surface of a virus for immunization, it is better to choose a 2A sequence variant that achieves the optimal epitope-to-CP ratio thus maximizing the number of epitopes presented to the immune system. When displaying fluorescent proteins on the surface of a virus for bioimaging applications or to track virus movement, the brightest fluorescence is achieved by maximizing the density of the fluorescent fusion, as shown for the CP~TMV~-iLOV direct fusion protein but not for the iLOV-2A-CP~TMV~ variant, which also produced ∼60% free iLOV polypeptide (**Figure [3](#F3){ref-type="fig"}**).

Transmission electron microscopy (**Figure [4](#F4){ref-type="fig"}**) confirmed the assembly of TMV particles displaying the iLOV polypeptide. Hybrid particles displaying iLOV were similar in shape and size to wild-type TMV particles, which are filamentous, rigid rods 300 nm in length. The hybrid particles were recognized by the iLOV-specific antibody which was detected in turn using a secondary antibody conjugated to 15-nm gold particles. Only a few particles were detected in leaves from plants expressing the CP~TMV~-iLOV and CP~TMV~-G~4~S-iLOV constructs, probably because most of the fluorescence (and therefore most of the hybrid virus particles) was retained in the stems. Another likely explanation could be the loss of the inserted iLOV sequence in the direct *cp* gene fusions, as indicated by RNA analysis and the detection of CP (**Figures [2B](#F2){ref-type="fig"}, [5](#F5){ref-type="fig"}**). Although the CP~TMV~-iLOV and CP~TMV~-G~4~S-iLOV viruses seem to be able to replicate, they could not move efficiently from cell-to-cell. There might be also mostly unmodified CP for the assembly available, but it seems not to be enough to compensate the sterically hindrance arising from the CP-iLOV fusion proteins. It can thus be speculated, that the remaining modification is detrimental to particle assembly, movement or phloem unloading. This might also be a possible explanation for the little CP~TMV~-iLOV and CP~TMV~-G~4~S-iLOV particles observed in electron micrographs. Gold labeling was especially prevalent for the iLOV-2A-CP~TMV~ and iLOV-2A-CP~PV\ X~ particles, indicating the incorporation of iLOV-2A-CP fusion proteins during virion assembly. Our findings therefore confirm that TMV vectors containing the FMDV 2A sequence are suitable for the production of hybrid TMV particles displaying proteins with a molecular weight of at least 13 kDa, and that the corresponding free polypeptide is also expressed at high levels. This strategy also means that not only the C-terminus, but also the N-terminus of the TMV CP becomes suitable for peptide display providing a nano-addressable virus scaffold.
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CP

:   coat protein

CPMV

:   Cowpea mosaic virus

dpi

:   days post-inoculation

FMDV

:   Foot-and-mouth disease virus

G~4~S

:   peptide linker consisting of four glycines and one serine, repeated 3 times

GAR^AP^

:   secondary alkaline phosphatase-conjugated goat-anti-rabbit antibody

GFP

:   green fluorescent protein

pI

:   isoelectric point

PBS

:   phosphate buffered saline

PVX

:   Potato virus X

ROS

:   reactive oxygen species

SGP

:   subgenomic promoter

TMV

:   Tobacco mosaic virus
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